MedLife S.A. — Board/Management Information 2021

Apr 27, 2021

No. 149/27 April 2021

To: BUCHAREST STOCK EXCHANGE FINANCIAL SUPERVISORY AUTHORITY

CURRENT REPORT

Current report drafted according to the stipulations of ASF Regulation no. 5/2018 on issuers of financial instruments and market operations and Law no. 24/2017 on issuers of financial instruments and market operations

Report Date: 27 April 2021

Name of the issuing company: MED LIFE S.A. ("MedLife" or "The Company")

Registered Office: Bucharest, Calea Grivitei, no. 365, district 1, Romania

Fax number: 0374 180 470

Unique Registration Code at the National Office of Trade Registry: 8422035

Order number on the Trade Registry: J40/3709/1996

Subscribed and paid-in share capital: 33,217,623 RON

Regulated market on which the issued securities are traded: Bucharest Stock Exchange, Premium Category

Significant events to report:

DECISION OF THE BOARD OF DIRECTORS OF MED LIFE S.A.

The Company informs its shareholders and investors that, by decision of the Board of Directors of the Company, the following was decided:

Considering the termination, by mutual agreement, of the mandate of Mrs. Geanina Durigu as Director of the Laboratories Division, and respectively as a member of the Executive Committee of the Company, the Board of Directors of Med Life S.A. adopted, by voting "for", unanimously expressed by all members, the following decision:

• Decision 1: Appointment of Mr. Marius Petrila, Director IT Department, as a member of the Executive Committee, the mandate being valid until 21.10.2024.

Mihail Marcu Chief Executive Officer

________________